These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2434662)

  • 1. Topographical rearrangements of visna virus envelope glycoprotein during antigenic drift.
    Stanley J; Bhaduri LM; Narayan O; Clements JE
    J Virol; 1987 Apr; 61(4):1019-28. PubMed ID: 2434662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variation in visna virus.
    Scott JV; Stowring L; Haase AT; Narayan O; Vigne R
    Cell; 1979 Oct; 18(2):321-7. PubMed ID: 227603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant gp135 to study epitope-specific antibody responses to maedi visna virus.
    Carey N; Roy DJ; Dalziel RG
    J Virol Methods; 1993 Jul; 43(2):221-32. PubMed ID: 7690044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor polypeptides to structural proteins of visna virus.
    Vigne R; Filippi P; Quérat G; Sauze N; Vitu C; Russo P; Delori P
    J Virol; 1982 Jun; 42(3):1046-56. PubMed ID: 6178845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.
    Skraban R; Matthíasdóttir S; Torsteinsdóttir S; Agnarsdóttir G; Gudmundsson B; Georgsson G; Meloen RH; Andrésson OS; Staskus KA; Thormar H; Andrésdóttir V
    J Virol; 1999 Oct; 73(10):8064-72. PubMed ID: 10482555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variation in the gp135 gene of Maedi visna virus strain EV1.
    Carey N; Dalziel RG
    Virus Genes; 1994 Mar; 8(2):115-23. PubMed ID: 8073632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic changes associated with antigenic variation of visna virus durig persistent infection.
    Clements JE; Pedersen FS; Narayan O; Haseltine WA
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4454-8. PubMed ID: 6254026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of a principal neutralization domain of visna/maedi virus envelope glycoprotein.
    Haflidadóttir BS; Matthíasdóttir S; Agnarsdóttir G; Torsteinsdóttir S; Pétursson G; Andrésson ÓS; Andrésdóttir V
    J Gen Virol; 2008 Mar; 89(Pt 3):716-721. PubMed ID: 18272763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of transgenic sheep that express the visna virus envelope gene.
    Clements JE; Wall RJ; Narayan O; Hauer D; Schoborg R; Sheffer D; Powell A; Carruth LM; Zink MC; Rexroad CE
    Virology; 1994 May; 200(2):370-80. PubMed ID: 8178428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for recombination in the envelope gene of maedi-visna virus.
    Andrésdóttir V
    Virus Genes; 2003 Aug; 27(1):5-9. PubMed ID: 12913353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.
    Narayan O; Clements JE; Griffin DE; Wolinsky JS
    Infect Immun; 1981 Jun; 32(3):1045-50. PubMed ID: 6166562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus.
    Correa I; Jiménez G; Suñé C; Bullido MJ; Enjuanes L
    Virus Res; 1988 Apr; 10(1):77-93. PubMed ID: 2453977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication.
    Crane SE; Clements JE; Narayan O
    J Virol; 1988 Aug; 62(8):2680-5. PubMed ID: 2455817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing and fusion-blocking antibodies induced by recombinant visna virus envelope glycoprotein.
    Huso DL
    Viral Immunol; 1997; 10(1):15-20. PubMed ID: 9095528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
    Fallahi F; Wandeler AI; Nadin-Davis SA
    Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120.
    Hötzel I; Cheevers WP
    J Virol; 2003 Nov; 77(21):11578-87. PubMed ID: 14557643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep.
    Lutley R; Pétursson G; Pálsson PA; Georgsson G; Klein J; Nathanson N
    J Gen Virol; 1983 Jul; 64 (Pt 7)():1433-40. PubMed ID: 6306145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic structure of envelope glycoprotein E1 of hog cholera virus.
    van Rijn PA; Miedema GK; Wensvoort G; van Gennip HG; Moormann RJ
    J Virol; 1994 Jun; 68(6):3934-42. PubMed ID: 7514680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins.
    Braun MJ; Clements JE; Gonda MA
    J Virol; 1987 Dec; 61(12):4046-54. PubMed ID: 2824836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.